Biologics and Biosimilars-Global Market Status and Trend Report 2014-2026

Biologics and Biosimilars-Global Market Status and Trend Report 2014-2026

Table of Contents

Chapter 1 Overview of Biologics and Biosimilars
1.1 Definition of Biologics and Biosimilars in This Report
1.2 Commercial Types of Biologics and Biosimilars
1.2.1 Monoclonal Antibodies
1.2.2 Interferon
1.2.3 Erythropoietin
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Other
1.3 Downstream Application of Biologics and Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Development History of Biologics and Biosimilars
1.5 Market Status and Trend of Biologics and Biosimilars 2014-2026
1.5.1 Global Biologics and Biosimilars Market Status and Trend 2014-2026
1.5.2 Regional Biologics and Biosimilars Market Status and Trend 2014-2026

Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Biologics and Biosimilars 2014-2019
2.2 Production Market of Biologics and Biosimilars by Regions
2.2.1 Production Volume of Biologics and Biosimilars by Regions
2.2.2 Production Value of Biologics and Biosimilars by Regions
2.3 Demand Market of Biologics and Biosimilars by Regions
2.4 Production and Demand Status of Biologics and Biosimilars by Regions
2.4.1 Production and Demand Status of Biologics and Biosimilars by Regions 2014-2019
2.4.2 Import and Export Status of Biologics and Biosimilars by Regions 2014-2019

Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Biologics and Biosimilars by Types
3.2 Production Value of Biologics and Biosimilars by Types
3.3 Market Forecast of Biologics and Biosimilars by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Biologics and Biosimilars by Downstream Industry
4.2 Market Forecast of Biologics and Biosimilars by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Biologics and Biosimilars
5.1 Global Economy Situation and Trend Overview
5.2 Biologics and Biosimilars Downstream Industry Situation and Trend Overview

Chapter 6 Biologics and Biosimilars Market Competition Status by Major Manufacturers
6.1 Production Volume of Biologics and Biosimilars by Major Manufacturers
6.2 Production Value of Biologics and Biosimilars by Major Manufacturers
6.3 Basic Information of Biologics and Biosimilars by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Biologics and Biosimilars Major Manufacturer
6.3.2 Employees and Revenue Level of Biologics and Biosimilars Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch

Chapter 7 Biologics and Biosimilars Major Manufacturers Introduction and Market Data
7.1 Roche
7.1.1 Company profile
7.1.2 Representative Biologics and Biosimilars Product
7.1.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Roche
7.2 Amgen
7.2.1 Company profile
7.2.2 Representative Biologics and Biosimilars Product
7.2.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Amgen
7.3 AbbVie
7.3.1 Company profile
7.3.2 Representative Biologics and Biosimilars Product
7.3.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of AbbVie
7.4 Sanofi-Aventis
7.4.1 Company profile
7.4.2 Representative Biologics and Biosimilars Product
7.4.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Biologics and Biosimilars Product
7.5.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Pfizer
7.6.1 Company profile
7.6.2 Representative Biologics and Biosimilars Product
7.6.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Pfizer
7.7 Novo Nordisk
7.7.1 Company profile
7.7.2 Representative Biologics and Biosimilars Product
7.7.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novo Nordisk
7.8 Eli Lilly
7.8.1 Company profile
7.8.2 Representative Biologics and Biosimilars Product
7.8.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Eli Lilly
7.9 Novartis
7.9.1 Company profile
7.9.2 Representative Biologics and Biosimilars Product
7.9.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novartis
7.10 Merck
7.10.1 Company profile
7.10.2 Representative Biologics and Biosimilars Product
7.10.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Merck
7.11 3sbio
7.11.1 Company profile
7.11.2 Representative Biologics and Biosimilars Product
7.11.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of 3sbio
7.12 Changchun High Tech
7.12.1 Company profile
7.12.2 Representative Biologics and Biosimilars Product
7.12.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Changchun High Tech
7.13 CP Guojian
7.13.1 Company profile
7.13.2 Representative Biologics and Biosimilars Product
7.13.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of CP Guojian
7.14 Biotech
7.14.1 Company profile
7.14.2 Representative Biologics and Biosimilars Product
7.14.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Biotech
7.15 Gelgen
7.15.1 Company profile
7.15.2 Representative Biologics and Biosimilars Product
7.15.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee

Chapter 8 Upstream and Downstream Market Analysis of Biologics and Biosimilars
8.1 Industry Chain of Biologics and Biosimilars
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Biologics and Biosimilars
9.1 Cost Structure Analysis of Biologics and Biosimilars
9.2 Raw Materials Cost Analysis of Biologics and Biosimilars
9.3 Labor Cost Analysis of Biologics and Biosimilars
9.4 Manufacturing Expenses Analysis of Biologics and Biosimilars

Chapter 10 Marketing Status Analysis of Biologics and Biosimilars
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs